Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $36,260 - $43,368
-3,608 Reduced 20.96%
13,607 $145,000
Q1 2024

May 14, 2024

BUY
$11.27 - $13.53 $15,563 - $18,684
1,381 Added 8.72%
17,215 $206,000
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $13,637 - $16,871
-1,555 Reduced 8.94%
15,834 $171,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $33,852 - $40,065
3,530 Added 25.47%
17,389 $171,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $45,532 - $51,943
-5,048 Reduced 26.7%
13,859 $138,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $43,083 - $57,413
4,683 Added 32.92%
18,907 $182,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $14,728 - $19,524
-1,689 Reduced 10.61%
14,224 $158,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $9,836 - $12,910
1,160 Added 7.86%
15,913 $136,000
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $15,243 - $18,797
-1,532 Reduced 9.41%
14,753 $154,000
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $138,016 - $216,662
-14,069 Reduced 46.35%
16,285 $177,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $11,328 - $13,755
-937 Reduced 2.99%
30,354 $411,000
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $8,943 - $10,212
-675 Reduced 2.11%
31,291 $424,000
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $93,954 - $116,990
-7,244 Reduced 18.47%
31,966 $457,000
Q1 2021

May 14, 2021

BUY
$13.59 - $18.54 $9,988 - $13,626
735 Added 1.91%
39,210 $548,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $550,192 - $721,021
38,475 New
38,475 $721,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.